Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
Publication date
2025-11
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Key changes in the pharmacoepidemiological research environment had a significant influence on the activities of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) over the last decade. These changes included the SARS-CoV-2 pandemic, the increased access to anonymized real-world data (RWD) sources, the integration of real-world evidence (RWE) into regulatory and public health decision-making, and the emergence of new technologies and methods. This paper describes how ENCePP has evolved in this changing environment to strengthen pharmacoepidemiological methods and practice in Europe and globally. It also provides future perspectives for the network. Through a collaborative approach in non-interventional research, ENCePP will collectively continue to promote excellence for RWE generation, supporting the safe and effective use of medicines.
Keywords
COVID-19/epidemiology, Europe/epidemiology, Humans, Pharmacoepidemiology/methods, Pharmacovigilance, SDG 3 - Good Health and Well-being
Citation
Kurz, X, Cohet, C, Perez-Gutthann, S, Rao, S & Gardarsdottir, H 2025, 'Strengthening Pharmacoepidemiology in a Changing Research Environment : The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)', Pharmacoepidemiology and Drug Safety, vol. 34, no. 11, e70263. https://doi.org/10.1002/pds.70263